Graham Capital Management, L.P. Invitae Corp Transaction History

Graham Capital Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.2 - $2.73 $497,444 - $1.13 Million	414,537 Added 45.08%	1,334,044 $1.8 Million
Q4 2022 Feb 14, 2023	BUY	$1.71 - $3.61 $1.57 Million - $3.32 Million	919,507 New	919,507 $1.71 Million
Q4 2021 Feb 14, 2022	SELL	$14.7 - $28.67 $838,414 - $1.64 Million	-57,035 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$24.31 - $33.6 $370,897 - $512,635	-15,257 Reduced 21.1%	57,035 $1.62 Million
Q2 2021 Aug 16, 2021	SELL	$26.09 - $40.4 $765,924 - $1.19 Million	-29,357 Reduced 28.88%	72,292 $2.44 Million

Q4 2020 Feb 16, 2021	BUY	$39.09 - $57.4 $3.97 Million - $5.83 Million	101,649 New	101,649 $4.25 Million

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.